Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. (AQST) Stock Overview

Explore Aquestive Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AQST●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.33
$0.08(1.70%)
U.S. Market is Open · 13:57

Aquestive Therapeutics, Inc. (AQST)

Meyka AI Score

Z

Key Financials

Market Cap530.7M
P/E Ratio-6.76
EPS (TTM)$-0.61
ROE2.44%
Fundamental Analysis

AI Price Forecasts

1 Month$4.19
3 Months$7.39
1 Year Target$5.95

AQST Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Aquestive Therapeutics, Inc. (NASDAQ: AQST) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Aquestive Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AQST on the NASDAQ shows an RSI of 57.51, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.95 for the NASDAQ listing.

Key metrics behind Aquestive Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.76 and a market capitalization of 530.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AQST on the NASDAQ.

Price Performance (NASDAQ: AQST)

1-Day Change
-4.08%
5-Day Change
7.09%
1-Month Change
2.67%
3-Month Change
1.68%
6-Month Change
12.80%
Year-to-Date (YTD) Change
-34.52%
1-Year Change
11.90%
3-Year Change
128.65%
5-Year Change
10.73%
All-Time (Max) Change
-73.64%

Contact Information

https://www.aquestive.com
908 941 1900
30 Technology Drive, Warren, NJ, 07059

Company Facts

1,470 Employees
IPO DateJul 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions